G. J. Offerhaus

Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.

J. Tijssen, J. Bergman, F. T. ten Kate, 2017, Gastroenterology.

Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's Esophagus.

J. Goldblum, M. Vieth, A. Bansal, 2017, Gastroenterology.

Patients With Barrett's Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer.

P. Siersema, G. Offerhaus, J. V. van Baal, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Endoscopic and pathological aspects of colitis-associated dysplasia

F. Vleggaar, P. Siersema, B. Oldenburg, 2009, Nature Reviews Gastroenterology &Hepatology.

Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.

J. Tijssen, E. Schoon, J. Bergman, 2014, JAMA.

The Amsterdam ReBus progressor cohort: identification of 165 Barrett's surveillance patients who progressed to early neoplasia and 723 nonprogressor patients.

E. Schoon, B. Weusten, R. Pouw, 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.